AU2022323465A1 - Method of treating veterinary viral diseases - Google Patents

Method of treating veterinary viral diseases Download PDF

Info

Publication number
AU2022323465A1
AU2022323465A1 AU2022323465A AU2022323465A AU2022323465A1 AU 2022323465 A1 AU2022323465 A1 AU 2022323465A1 AU 2022323465 A AU2022323465 A AU 2022323465A AU 2022323465 A AU2022323465 A AU 2022323465A AU 2022323465 A1 AU2022323465 A1 AU 2022323465A1
Authority
AU
Australia
Prior art keywords
animal
virus
days
viral
feline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022323465A
Other languages
English (en)
Inventor
Willem Huisman
Edward Murray
Basav Hangalapura NAGARAJ
Joachim Ullrich
Ralf Warrass
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of AU2022323465A1 publication Critical patent/AU2022323465A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2022323465A 2021-08-06 2022-08-05 Method of treating veterinary viral diseases Pending AU2022323465A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21190172 2021-08-06
EP21190172.3 2021-08-06
EP22185716 2022-07-19
EP22185716.2 2022-07-19
PCT/EP2022/072074 WO2023012329A1 (en) 2021-08-06 2022-08-05 Method of treating veterinary viral diseases

Publications (1)

Publication Number Publication Date
AU2022323465A1 true AU2022323465A1 (en) 2024-02-01

Family

ID=83151800

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022323465A Pending AU2022323465A1 (en) 2021-08-06 2022-08-05 Method of treating veterinary viral diseases

Country Status (8)

Country Link
US (1) US20240342204A1 (https=)
EP (1) EP4380578A1 (https=)
JP (1) JP2024528237A (https=)
AU (1) AU2022323465A1 (https=)
BR (1) BR112024002195A2 (https=)
CA (1) CA3226836A1 (https=)
MX (1) MX2024001645A (https=)
WO (1) WO2023012329A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL300412A (en) 2020-08-24 2023-04-01 Gilead Sciences Inc Phospholipid compounds and their uses
TW202344257A (zh) 2020-10-16 2023-11-16 美商基利科學股份有限公司 磷脂化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5030587B2 (ja) 2003-06-26 2012-09-19 バイオトロン・リミテッド 抗ウイルスアシルグアニジン化合物および方法
NZ615939A (en) 2011-05-10 2015-04-24 Aratana Therapeutics Nv Compounds for use in the treatment of feline retroviral infections
GB201203180D0 (en) 2012-02-24 2012-04-11 Okapi Sciences Nv Compounds for treating parvovirus infection
JP7381190B2 (ja) 2014-12-26 2023-11-15 エモリー・ユニバーシテイ Ｎ４－ヒドロキシシチジン及び誘導体並びにそれに関連する抗ウイルス用途
PT3706762T (pt) 2017-12-07 2024-12-05 Univ Emory N4-hidroxicitidina e derivados e utilizações antivirais relacionadas com os mesmos
KR20200140274A (ko) 2018-03-07 2020-12-15 에모리 유니버시티 4'-할로겐 함유 뉴클레오티드 및 뉴클레오시드 치료 조성물 및 이와 관련된 용도

Also Published As

Publication number Publication date
CA3226836A1 (en) 2023-02-09
WO2023012329A1 (en) 2023-02-09
JP2024528237A (ja) 2024-07-26
US20240342204A1 (en) 2024-10-17
MX2024001645A (es) 2024-02-27
EP4380578A1 (en) 2024-06-12
BR112024002195A2 (pt) 2024-04-30

Similar Documents

Publication Publication Date Title
Loeffen et al. Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infection with an influenza H1N1 virus
JP2017525681A (ja) パラミクソウイルスの治療方法
US20090247481A1 (en) Compositions and Kits for Treating Influenza
US20240342204A1 (en) Method of treating veterinary viral diseases
ES2877808T3 (es) Producto combinado para tratar o mejorar una infección por virus respiratorio sincicial
KR20180124970A (ko) 바이러스 감염을 치료하기 위한 티아졸리드 화합물
KR101929141B1 (ko) 돼지 사료에서의 나라신의 항바이러스 효과
JP7293225B2 (ja) 組合せ製品を用いるｒｓｖの処置
WO2026001078A1 (zh) 针对蓝耳病毒的新型药物
CN117858710A (zh) 治疗兽医学病毒性疾病的方法
US20250332170A1 (en) Vandetanib reduces inflammatory cytokines and ameliorates covid-19
JP2024529291A (ja) ウイルス感染症の処置および予防のための組成物および方法
Crawford et al. Efficacy of ivermectin administration to growing pigs after a virulent porcine reproductive and respiratory syndrome virus 1-4-4 L1C challenge
RU2292220C1 (ru) Способ профилактики инфекционного ринотрахеита и парагриппа-3 крупного рогатого скота
EP4611757A1 (en) Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
Jaramillo Immune Response and Protection Against BVDV-2 and BHV-1 Infection Elicited by Modified-Live Virus Vaccination in Dairy Calves. Effects of Vaccination Route and Trace Mineral Injection
Rout Carrier state in domestic and wildlife species: a debatable issue of concern in the epidemiology of foot-and-mouth disease
HK40085365A (en) Remdesivir treatment methods
RU2308269C1 (ru) Способ профилактики вирусной диареи - болезни слизистых крупного рогатого скота у телят при помощи противовирусного препарата йодантипирин
CA3231644A1 (en) Compositions and methods for enhancing and expanding infection induced immunity
CN120919125A (zh) 一种抗病原体感染的组合物及其应用
KR20230043279A (ko) 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물
HK40046324A (zh) 用於治疗rsv的组合产品
German Tissue specific pathology associated with micronutrient supplementation during respiratory syncytial virus infection
US20170143661A1 (en) Method for reducing the viral load in poultry challenged with newcastle disease (nd)/ avian influenza (ai)